Sur vs Yemen: Previously treated cases tested for RR-/MDR-TB
Sur
62.0%
in 2024
Yemen
100.0%
in 2024
Sur rank
2nd
Yemen rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Sur
- Yemen
How they compare
Yemen currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Yemen's figure about 1.6 times Sur's.
The two have swapped places 3 times across 14 shared years of data; in 2008 it was Sur ahead.
Sur ranks 2nd and Yemen ranks 1st of 2 regions.
Sur has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sur | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.5% | 11.8% | 9.7% | Sur |
| 2010s | 55.0% | 23.4% | 31.6% | Sur |
| 2020s | 78.4% | 60.0% | 18.4% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sur or Yemen?
- Yemen, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sur and Yemen?
- 38.0%, with Yemen ahead.
- How many years of comparable data are there for Sur and Yemen?
- 14 years are reported by both, from 2008 to 2024.
- How do Sur and Yemen rank globally for previously treated cases tested for rr-/mdr-tb?
- Sur ranks 2nd and Yemen ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.